Gland Pharma Limited has informed the Exchange about Options to purchase securities
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma's ESOP Compensation Committee has approved the grant of 690,019 employee stock options to 124 employees under ESOP 2025. Of the total options, 455,413 are priced at INR 934.15 per share (50% of the NSE closing price on May 15, 2026), while 234,606 options are priced at INR 1 (face value). The options will vest over three years: 34% after one year (May 15, 2027), 33% after two years (May 15, 2028), and 33% after three years (May 15, 2029). Employees can exercise these options within two years from the date of vesting. The grant complies with SEBI regulations governing share-based employee benefits.
This is a routine corporate governance disclosure about employee compensation through equity participation. It has no direct impact on the company's revenue, orders, or business operations. It may have a minor positive signaling effect regarding employee retention and alignment of interests with shareholders.